Correlation Between Clinical Measurement Scales for Gross Motor Function
Sponsor
Cairo University (Other)
Overall Status
Completed
CT.gov ID
NCT06124352
Collaborator
(none)
50
1
4.7
10.6
Study Details
Study Description
Brief Summary
Evaluating and applying an early and consistent rehabilitation approach to children with neurological impairments requires a multidisciplinary approach that involves different specialists, including pediatricians, pediatric neurologists, professional therapists, and pediatric physical therapists. Evaluation is essential to validate the judgment, monitor the source, and evaluate the mechanical function and related difficulties.
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
Study Design
Study Type:
Observational
Actual Enrollment
:
50 participants
Observational Model:
Case-Crossover
Time Perspective:
Cross-Sectional
Official Title:
Correlation Between Clinical Measurement Scales for Gross Motor Function in Children With Spastic Cerebral Palsy
Actual Study Start Date
:
May 15, 2023
Actual Primary Completion Date
:
Aug 28, 2023
Actual Study Completion Date
:
Oct 6, 2023
Outcome Measures
Primary Outcome Measures
- The principal purpose of this study is to find the correlation between the clinical measurement scales for gross motor function in young CP children [6 months]
For this study, a correlation between these 3 categories of clinical measures scales was analyzed in diplegic patients.
Eligibility Criteria
Criteria
Ages Eligible for Study:
4 Years
to 6 Years
Sexes Eligible for Study:
All
Inclusion Criteria:
- children with spastic CP with the capability to keep a standing position alone for at minimum five seconds, and the grade of hypertonicity in the lower extremity varied from grade 1 to grade 2 on the Modified Ashworth Scale with the capability to collaborate and follow directives
Exclusion Criteria:
- Children were excluded If they had a serious neurological condition (epilepsy), orthopedic complications, leg surgery, botulinum toxin treatment in the lower extremity in the last 6 months before the study and suffered from advanced intellectual disability.
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | Cairo University | Giza | Egypt | 11234 |
Sponsors and Collaborators
- Cairo University
Investigators
None specified.Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
Shimaa Mohamed Reffat,
lecturer at faculty of physical therapy,
Cairo University
ClinicalTrials.gov Identifier:
NCT06124352
Other Study ID Numbers:
- Clinical Measure Scales
First Posted:
Nov 9, 2023
Last Update Posted:
Nov 9, 2023
Last Verified:
Nov 1, 2023
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms: